A detailed history of Janus Henderson Group PLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,791,937 shares of TEVA stock, worth $81.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,791,937
Previous 59,563 7945.16%
Holding current value
$81.6 Million
Previous $967,000 8829.68%
% of portfolio
0.05%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $74.8 Million - $89.7 Million
4,732,374 Added 7945.16%
4,791,937 $86.4 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $51,933 - $74,290
-6,943 Reduced 10.44%
59,563 $607,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $86,428 - $113,677
-12,004 Reduced 15.29%
66,506 $500,000
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $1.29 Million - $1.82 Million
-174,923 Reduced 69.02%
78,510 $591,000
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $188,967 - $242,074
25,780 Added 11.32%
253,433 $2.38 Million
Q3 2021

Nov 16, 2021

SELL
$8.38 - $10.18 $188,013 - $228,398
-22,436 Reduced 8.97%
227,653 $2.22 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $411,998 - $481,080
41,616 Added 19.96%
250,089 $2.48 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $55,070 - $68,226
5,326 Added 2.62%
208,473 $2.41 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $182,910 - $234,533
-21,244 Reduced 9.47%
203,147 $1.96 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $283,786 - $420,216
33,114 Added 17.31%
224,391 $2.02 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $517,974 - $836,924
63,790 Added 50.04%
191,277 $2.36 Million
Q1 2020

May 14, 2020

SELL
$6.69 - $13.45 $1.14 Million - $2.29 Million
-170,377 Reduced 57.2%
127,487 $1.14 Million
Q4 2019

Feb 18, 2020

SELL
$6.53 - $10.72 $2.4 Million - $3.94 Million
-367,784 Reduced 55.25%
297,864 $2.92 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $4.24 Million - $6.61 Million
-688,287 Reduced 50.84%
665,648 $4.58 Million
Q2 2019

Jul 31, 2019

BUY
$8.12 - $15.72 $8.94 Million - $17.3 Million
1,100,481 Added 434.19%
1,353,935 $12.5 Million
Q1 2019

Apr 30, 2019

SELL
$15.58 - $20.01 $16.1 Million - $20.7 Million
-1,033,267 Reduced 80.3%
253,454 $3.97 Million
Q4 2018

Feb 06, 2019

BUY
$14.59 - $23.84 $16.7 Million - $27.3 Million
1,145,300 Added 809.85%
1,286,721 $19.8 Million
Q3 2018

Nov 09, 2018

BUY
$21.06 - $25.65 $305,370 - $371,925
14,500 Added 11.42%
141,421 $3.05 Million
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $1,291 - $2,196
-115 Reduced 0.09%
126,921 $2.41 Million
Q3 2017

Nov 14, 2017

SELL
$15.41 - $32.17 $46.4 Million - $96.9 Million
-3,011,051 Reduced 95.95%
127,036 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,138,087
3,138,087 $104 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.